Neuraxpharm Uk Limited is a private limited company registered at Tudor House, 16 Cathedral Road, Cardiff CF11 9LJ. Its total net worth is valued to be roughly 0 pounds, while the fixed assets belonging to the company total up to 0 pounds. Incorporated on 2017-08-16, this 6-year-old company is run by 2 directors.
Director Maximilian V., appointed on 10 January 2023. Director Mark S., appointed on 10 October 2022.
The company is officially categorised as "wholesale of pharmaceutical goods" (SIC: 46460). According to official data there was a change of name on 2017-11-14 and their previous name was Nupharm Uk Holding Limited.
The last confirmation statement was sent on 2023-08-15 and the due date for the next filing is 2024-08-29. Likewise, the accounts were filed on 31 December 2022 and the next filing should be sent on 30 September 2024.
Office Address | Tudor House |
Office Address2 | 16 Cathedral Road |
Town | Cardiff |
Post code | CF11 9LJ |
Country of origin | United Kingdom |
Registration Number | 10918621 |
Date of Incorporation | Wed, 16th Aug 2017 |
Industry | Wholesale of pharmaceutical goods |
End of financial Year | 31st December |
Company age | 7 years old |
Account next due date | Mon, 30th Sep 2024 (155 days left) |
Account last made up date | Sat, 31st Dec 2022 |
Next confirmation statement due date | Thu, 29th Aug 2024 (2024-08-29) |
Last confirmation statement dated | Tue, 15th Aug 2023 |
The register of PSCs that own or have control over the company is made up of 1 name. As we established, there is Permira Vii Investment Platform Limited from London, England. The abovementioned PSC is categorised as "a limited company", has 75,01-100% voting rights and has 75,01-100% shares. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares.
Permira Vii Investment Platform Limited
80 Pall Mall, London, SW1Y 5ES, England
Legal authority | Companies Act |
Legal form | Limited Company |
Country registered | United Kingdom |
Place registered | United Kingdom |
Registration number | 12263614 |
Notified on | 16 December 2020 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights |
Nupharm Uk Holding | November 14, 2017 |
Profit & Loss | ||||||
---|---|---|---|---|---|---|
Accounts Information Date | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
Balance Sheet | ||||||
Cash Bank On Hand | 5 000 | 310 086 | 1 222 646 | 89 044 | 278 052 | 237 574 |
Current Assets | 5 000 | 328 073 | 2 506 447 | 2 889 454 | 8 355 238 | 7 166 735 |
Debtors | 17 987 | 826 419 | 887 999 | 3 215 198 | 3 768 656 | |
Net Assets Liabilities | 5 000 | 208 284 | 267 703 | 300 589 | 382 589 | |
Other Debtors | 17 987 | 51 795 | 66 707 | 289 660 | 87 412 | |
Property Plant Equipment | 4 402 | 5 869 | 4 127 | 2 877 | ||
Total Inventories | 457 382 | 1 912 411 | 4 861 988 | 3 160 505 | ||
Other | ||||||
Accumulated Amortisation Impairment Intangible Assets | 8 525 | 101 622 | 402 548 | 718 575 | 1 060 166 | |
Accumulated Depreciation Impairment Property Plant Equipment | 1 100 | 2 843 | 4 585 | 6 451 | ||
Additions Other Than Through Business Combinations Intangible Assets | 138 558 | 439 079 | ||||
Additions Other Than Through Business Combinations Property Plant Equipment | 5 502 | |||||
Administrative Expenses | 47 776 | 984 793 | ||||
Amortisation Expense Intangible Assets | 8 525 | 93 097 | ||||
Amortisation Rate Used For Intangible Assets | 20 | 20 | ||||
Average Number Employees During Period | 1 | 3 | 4 | 6 | 7 | |
Comprehensive Income Expense | -96 716 | 59 419 | ||||
Cost Sales | 46 448 | 1 153 130 | ||||
Creditors | 249 822 | 2 584 161 | 3 766 915 | 196 293 | 2 604 206 | |
Depreciation Expense Property Plant Equipment | 1 100 | |||||
Fixed Assets | 130 033 | 480 417 | 944 626 | 844 860 | 600 300 | |
Gross Profit Loss | -46 448 | 1 056 009 | ||||
Income Expense Recognised Directly In Equity | 300 000 | |||||
Increase From Amortisation Charge For Year Intangible Assets | 8 525 | 93 097 | 300 926 | 316 027 | 341 591 | |
Increase From Depreciation Charge For Year Property Plant Equipment | 1 100 | 1 743 | 1 742 | 1 866 | ||
Intangible Assets | 130 033 | 476 015 | 938 757 | 840 733 | 597 423 | |
Intangible Assets Gross Cost | 138 558 | 577 637 | 1 341 305 | 1 559 308 | 1 657 589 | |
Interest Payable Similar Charges Finance Costs | 2 492 | 11 797 | ||||
Issue Equity Instruments | 300 000 | |||||
Net Current Assets Liabilities | 5 000 | 78 251 | -77 714 | -877 461 | -347 978 | 2 386 495 |
Operating Profit Loss | -94 224 | 71 216 | ||||
Other Creditors | 196 928 | 560 494 | 593 718 | 239 624 | 312 285 | |
Other Taxation Social Security Payable | 4 844 | 260 770 | 241 650 | 29 183 | 863 388 | |
Profit Loss | -96 716 | 59 419 | ||||
Profit Loss On Ordinary Activities Before Tax | -96 716 | 59 419 | ||||
Property Plant Equipment Gross Cost | 5 502 | 8 712 | 8 712 | 9 328 | ||
Total Assets Less Current Liabilities | 5 000 | 208 284 | 402 703 | 67 165 | 496 882 | 2 986 795 |
Trade Creditors Trade Payables | 48 050 | 1 762 897 | 2 796 547 | 199 792 | 66 751 | |
Trade Debtors Trade Receivables | 774 624 | 821 292 | 2 520 240 | 3 475 461 | ||
Turnover Revenue | 2 209 139 | |||||
Amounts Owed By Group Undertakings | 405 297 | 205 783 | ||||
Amounts Owed To Group Undertakings | 196 293 | 2 604 206 | ||||
Number Shares Issued Fully Paid | 305 000 | |||||
Par Value Share | 1 | 1 | ||||
Total Additions Including From Business Combinations Intangible Assets | 763 668 | 218 003 | 98 281 | |||
Total Additions Including From Business Combinations Property Plant Equipment | 3 210 | 616 | ||||
Number Shares Allotted | 5 000 |
Type | Category | Free download | |
---|---|---|---|
PSC02 |
Notification of a person with significant control 16th December 2020 filed on: 21st, February 2024 |
persons with significant control | Free Download (2 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy